KPC Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000015P8
CNY
11.40
-4.25 (-27.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,824.01
1,399.86
1,742.90
1,594.34
2,943.99
2,005.34
1,867.74
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,824.01
1,399.86
1,742.90
1,594.34
2,943.99
2,005.34
1,867.74
Raw Material Cost
1,189.77
888.26
1,031.46
1,045.10
1,555.17
1,138.85
1,043.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.27
12.84
13.74
13.73
6.73
6.11
6.96
Selling and Distribution Expenses
572.51
501.90
544.21
391.24
916.52
595.90
639.56
Other Expenses
1.65
1.31
0.49
0.57
3.76
1.99
1.36
Total Expenditure (Excl Depreciation)
1,789.06
1,416.11
1,594.33
1,455.82
2,516.03
1,760.79
1,703.51
Operating Profit (PBDIT) excl Other Income
34.900000000000006
-16.200000000000003
148.6
138.5
428
244.60000000000002
164.20000000000002
Other Income
63.31
6.96
35.63
27.11
45.27
31.04
77.92
Operating Profit (PBDIT)
113.18
23.91
212.08
212.53
490.27
256.73
262.53
Interest
10.27
12.84
13.74
13.73
6.73
6.11
6.96
Exceptional Items
-11.74
119.21
1.25
0.19
7.09
-2.26
2.40
Gross Profit (PBDT)
634.23
511.60
711.43
549.24
1,388.83
866.49
824.37
Depreciation
50.58
50.58
49.84
49.84
53.36
0.00
51.85
Profit Before Tax
40.59
79.69
149.75
149.16
437.28
248.36
206.13
Tax
-0.51
6.00
13.47
35.55
76.36
60.78
35.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
80.57
71.01
107.87
90.48
260.69
173.35
140.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
80.57
71.01
107.87
90.48
260.69
173.35
140.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
15.08
2.47
28.50
23.07
100.02
14.02
30.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
95.65
73.48
136.37
113.55
360.71
187.37
170.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,362.26
5,308.84
5,226.96
5,345.43
5,253.65
5,532.50
5,375.45
Earnings per share (EPS)
0.11
0.09
0.14
0.12
0.34
0.23
0.18
Diluted Earnings per share
0.11
0.09
0.14
0.12
0.34
0.23
0.18
Operating Profit Margin (Excl OI)
-0.04%
-2.4%
7.26%
8.5%
13.3%
11.25%
7.11%
Gross Profit Margin
5.0%
9.31%
11.45%
12.48%
16.67%
12.38%
13.81%
PAT Margin
4.42%
5.07%
6.19%
5.68%
8.85%
8.64%
7.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 30.30% vs -19.68% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 30.07% vs -46.11% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 195.27% vs -90.42% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -19.53% vs -6.57% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of KPC Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,824.01
0
1,824.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,824.01
0
1,824.01
Raw Material Cost
1,189.77
0
1,189.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.27
0
10.27
Selling and Distribution Expenses
572.51
0
572.51
Other Expenses
1.65
0.00
1.65
Total Expenditure (Excl Depreciation)
1,789.06
0
1,789.06
Operating Profit (PBDIT) excl Other Income
34.95
0.00
34.95
Other Income
63.31
0
63.31
Operating Profit (PBDIT)
113.18
0
113.18
Interest
10.27
0
10.27
Exceptional Items
-11.74
0
-11.74
Gross Profit (PBDT)
634.23
0
634.23
Depreciation
50.58
0
50.58
Profit Before Tax
40.59
0
40.59
Tax
-0.51
0
-0.51
Provisions and contingencies
0
0
0.00
Profit After Tax
80.57
0
80.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
80.57
0
80.57
Share in Profit of Associates
0
0
0.00
Minority Interest
15.08
0
15.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
95.65
0
95.65
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,362.26
0
5,362.26
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
-0.04%
0%
0.00
-0.04%
Gross Profit Margin
5.00%
0%
0.00
5.00%
PAT Margin
4.42%
0%
0.00
4.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 182.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 30.30% vs -19.68% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -38.04% vs 40.71% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.56 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 30.07% vs -46.11% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -73.50% vs 522.97% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.99 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 195.27% vs -90.42% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -88.79% vs 367.44% in Dec 2024

Quarterly - Interest
Interest 1.03 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -19.53% vs -6.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 53.73% vs -34.31% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.04%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024